Emergency Care Updates
This page is intended for Healthcare Professionals Only
Currently only a few treatments available help mildly ill patients – people who have COVID-19 who do not require admission to hospital. Drugs like azithromycin, bamlanivimab, colchicine, hydroxychloroquine, ivermectin, lopinavir-ritonavir, and vitamin D do not help patients with COVID-19, and may cause harm.
Dexamethasone, a steroid that can be given in pill form, may benefit patients who are at home but need supplemental oxygen, but does not help patients who are mildly ill who do not need supplemental oxygen.
Budesonide, a steroid that can be inhaled (from a “puffer”), has no effect on whether patients with mild COVID-19 get sicker, are hospitalized, or die. But there is weak evidence that inhaled budesonide 800 mcg twice daily for 14 days may make patients feel better a few days earlier, so doctors may consider prescribing it.
These consolidated guidelines for the prevention, control and management COVID-19 in Kenya provide updated recommendations for comprehensive prevention and case management strategies in Kenya. They cover infection prevention and control measures including the use of vaccines. They also target the diagnosis and case management of COVID-19.
The Emergency Department in a hospital is open and staffed 24 hours a day 7 days a week to handle patients who present without prior appointment with a mix of injuries and acute illnesses either by their own means or by that of an ambulance. Check out our resources page for more ED Resources.